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ABSTRACT
BKV and JCV belong to the Polyomaviridae family and are opportunistic agents 
associated with complications in immunocompromised individuals. Although a single 
screening assay for both viruses would be convenient, the diversity of BKV and JCV serotypes 
and genotypes is a methodological challenge. In this paper, we developed a PCR method 
able to detect and segregate BKV and JCV, despite these genetic discrepancies. A duplex 
semi-nested PCR (duplex snPCR) was designed to target a conserved region (639nt-1516nt) 
within the VP2 gene. In the first PCR, a primer set common to all BKV and JCV serotypes/
genotypes was used, followed by a semi-nested PCR with internal primers for BKV and JCV 
segregation. The limit of detection of the duplex snPCR was as low as 10 copies of BKV or 
JCV plasmids/µL. Specific products were observed when JCV and BKV plasmids were mixed 
in the same reaction. In field sample testing, the duplex snPCR detected and distinguished 
both viruses in different biological samples. Results were confirmed by Sanger’s sequencing. 
The geographical complexity of BKV and JCV serotypes and genotypes imposes limits to 
a simple and universal method that could detect each virus. However, we describe here a 
sensitive and reliable PCR technique for BKV and JCV diagnosis that overcomes these 
limitations and could be universally applied. 
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BKV and JVC belong to the Polyomaviridae family and are small (40-45 nm), 
non-enveloped double-stranded DNA viruses (~5000 pb) with a high prevalence in 
the population, estimated as high as 80% and 70% for BKV and JCV, respectively1. 
The most common complications caused by BKV are the nephropathy (NPV) 
and hemorrhagic cystitis (HC) in renal transplant recipients, whereas the JCV is 
associated with progressive multifocal leukoencephalopathy (PML) in HIV-positive 
patients and in those with multiple sclerosis treated with natalizumab2,3. Recently, 
BKV and JCV have also been associated to some types of neoplasms4-6 requiring 
further investigations.
In general, BKV and JCV can be detected in urine, whole blood, plasma, 
serum, tissues and rarely in cerebrospinal fluid (CSF)2. The diagnostic methods 
include cytological examination, immunofluorescent staining, enzyme-linked 
immunosorbent assay (ELISA) and polymerase chain reaction (PCR)7-9. The latter 
is the method of choice to detect active BKV replication in urine or blood since 
anti-BKV antibodies detection is not helpful and viral isolation is time-consuming6. 
For JCV, the immunohistochemistry of brain biopsies and PCR of CSF are the most 
accurate to diagnose PML10.
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Asmembers of the same viral family which are 
associated to disease in immunocompromised individuals, 
the development of a single discriminative test for both 
viruses is attractive. In addition, cases of JCV nephropathy 
have been reported in literature8, supporting the need for 
an accurate identification of these agents. Although the 
use of quantitative real-time based assays became the 
standard diagnosis for both viruses, especially for BK in 
plasma, a cost-saving sensitive screening method would be 
helpful, especially in limited resourced centers that could 
not afford the high costs involved in the real-time PCR. 
However, due to genetic similarities (above 70%) and a 
diversity of serotypes and genotypes11, the differentiation 
of BKV and JCV by molecular methods is challenging. 
Therefore, the goal of the present study was to design a 
PCR methodology to detect and differentiate BKV and 
JCV in clinical samples.
A duplex semi-nested PCR was designed targeting a 
conserved genomic region of the minor capsid protein VP2. 
To this end, VP2 sequences from all BKV viruses [V01108 
(Ia), AB211371 (Ib1), AB211370 (Ib2), AB211375 (Ic), 
AB263916 (II), AB211386 (III), AB211387 (IV)] and 
JCV genotypes [J02226 (1A), AF015527 (1B), AF030085 
(2A), AF015532 (2B), AF015534 (2C), AF015536 (2D), 
AF281606 (2E), U73500 (3A), U73501 (3B), AF015528 
(4), AF015537 (6), U61771 (7)], available at GenBank 
database were aligned with the aid of the Molecular 
Evolutionary Genetics Analysis version 7.0 (MEGA 7.0)12 
software in search of potential regions for primer alignment. 
A region comprising ~870 pb (639 nt-1516 nt) was chosen 
due to its conservation along BKV and JCV genotypes, as 
well as its potential to discriminate between the viruses 
(Figure 1).
In the first round of amplification, the forward primer 
BKJCf [5’-GCACTTTTGGGGGACCTAGT-3’; (nt 639-657 
in BKV and nt 541-559 in JCV)] and the reverse primer BKJCr 
[5’-GGCAACATCCATTGAGGAG-3’; (nt 1,511-1,492 in 
BKV and nt 1,416-1,397 in JCV)] were used as they were 
common for both viruses. For the second round, the forward 
primers were designed to distinguish between BKV [BKf: 
5’-GGACAATTGTAAATGCCCCYAT-3’; (nt 1228-1249)], 
and JCV [JCf: 5’-CCAAAGGGAGGGAACCTATATT-3’; 
(nt 1227-1248)], combined with the reverse primer BKJCr, 
already used in the first round. Due to a substitution of a 
T→C at the position 1,247 of BK genotype III, a degeneration 
(Y) was inserted at the 20th position of BKf primer. The 
inner primer set amplified a 284 bp fragment for BKV and 
190 bp for JCV (Figure 1). The specificity of both pair primer 
pairs was confirmed with the aid of the BLASTn software, 
resulting in 100% similarity with BKV and/or JCV. 
PCR mixture for both PCR steps contained 2.5 µL of 
10X PCR buffer (200 mM Tris-HCl pH 8.4 and 500 mM 
KCl), 0.75 µL of 50 mM MgCl2, 0.2 µL of 100 mM dNTP 
mixture, 0.2 µL of the 5 U/µL Taq polymerase enzyme 
(Invitrogen, Thermofischer Scientific, USA), 0.5 µL of 
each 25 µM forward and reverse primers in the first round, 
but in the second round 0.5 µL of each 25 µM forward 
primer and 1µL of the 25 µM reverse primer. The reaction 
mixture was adjusted to 25 µL of final volume with 
ultrapure water (Ambion, USA). In the first round 2 µL 
of DNA was added to the mixture, while in the second 
step 2 µL of the first PCR product was diluted 1:100 in 
ultrapure water and 2 µL of the dilution was added. The 
Thermal Cycling of both PCR rounds consisted of an 
initial denaturation step of 5 min at 9 ºC, following 40 
cycles of 55 s at 94 ºC, 50 s at 55 ºC and 55 s at 72 ºC, and 
a final extension of 5 min at 72 ºC. The BKV and JCV VP2 
amplicons were visualized on 1.5% agarose gels stained 
with 0.02% ethidium bromide.
As the internal reaction control, in-house designed 
primers (BAF1: 5’-AAGAGAGGCATCCTCACCCT-3’; 
and BAR2: 5’-TACATGGCTGGGGTGTTGAA-3’), 
amplifying a 220 bp fragment of the beta-actin gene13 
were used in the same cycling and reaction conditions, 
as described for the first round of PCR for BKV and JCV 
detections.
Figure 1 - Product sizes in the 1st and the 2nd (nested) PCR in BKV (V01108, Dunlop strain) and JCV (J02226, Mad1 strain) VP2 
sequences
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The sensitivity of the reaction was evaluated with 
plasmids containing complete genomes of BKV and JCV. 
The theoretical plasmid copy number was calculated using 
the ENDMEMO software available at www.endmemo.com/
bio/dnacopynum.php, which is based on the size (in base-
pairs) of each plasmid, the average nucleotide molecular 
weight and DNA quantity. The plasmids were quantified 
by the Nanodrop Spectophotometer (ThermoFisher 
Scientific®, USA) at 260 nm wave length 10-fold diluted 
in TE (Tris-EDTA) buffer (ThermoFisher Scientific®, 
USA). The 1010 to 10 copies per microliter dilutions were 
subsequently submitted to the duplex-snPCR. A mixture 
of BKV and JCV plasmids were also tested to check 
out the capacity of PCR to co-detect both viruses in the 
same sample. Finally, 87 clinical samples (60 whole 
blood; 21 urines; 5 plasma samples; 1 renal biopsy) from 
renal transplant patients, one per individual, were tested. 
Samples were stored at -80 °C until DNA was extracted. 
Biopsies and 200 µL of whole blood samples DNA were 
extracted by the RTP® DNA/RNA Virus Mini Kit (Stratec 
Molecular Biomedical - Berlin, Germany) according to 
the manufacturer’s instructions, while 200 µL of urine and 
plasma samples DNA were extracted by the PureLink™ Viral 
RNA/DNA Mini Kit (ThermoFisher Scientific®, USA), also 
according to the manufacturer’s instructionsSamples were 
all eluated in 50 µL of TE buffer provided by the extraction 
kits. This study was approved by the Ethic Committee 
of the Hospital Universitario Clementino Fraga Filho 
(CAAE Nº 43624814.2.0000.5262). 
The duplex snPCR could detect as few as 10 copies 
of template plasmidic DNA of each virus per microliter 
(Figure 2). It was also able to co-detect JCV and BKV 
in the same mixture (Figure 3). Moreover, sn-PCR was 
conducted to test the cross-reactivity between second 
round BKV and JCV primers and JCV BKV plasmids, 
respectively, revealing that the designed primers do not 
amplify non-specific plasmids. Of the clinical samples, 34 
(39%) were positive for any of the two viruses, of which 
31(35.6%) were positive for BKV and 3 (3.4%) for JCV. 
Regarding the sample type, JCV was detected only in urine, 
while BKV was detected in 11 urine samples, one kidney 
tissue fragment and 19 whole blood samples. None of the 
viruses were detected in plasma samples. No dual detection 
was observed in the tested samples and all of them were 
positive for the beta-actin reaction.
BKV and JCV share many genetic and biological 
properties, but are associated with different illnesses4. 
Meanwhile, other pathogenic properties of both viruses 
need further investigation, especially concerning their 
association with different neoplasias14. 
In this study, a duplex semi-nested PCR was developed 
to detect and discriminate BKV and JCV in diverse types of 
clinical samples. The technique was proven highly sensitive, 
as observed by the limit of detection of 10 copies per µL. In 
addition, the primer sets chosen after extensive alignment of 
the different BKV and JCV genomes, and confirmed by the 
BLAST analysis, confirmed their inclusiveness. In addition, 
the results obtained with acellular (urine supernatant, 
plasma) and cellular (tissue, whole blood) clinical samples, 
indicate a wider application. 
The development of a reliable multiplex tool for the 
identification of polyomaviruses is not trivial, which may 
Figure 3 - Agarose gel showing the duplex snPCR products. 
Lines 2 and 3: 284 bp BKV fragment; lines 6 and 7: JCV 190 bp 
fragment; line 4: JCV and BKV dual detection; lines 1 and 
5: 50 DNA bp ladder (New England Biolabs, USA)
Figure 2 - Agarose gel showing the limit of detection for JCV (190 pb): A) and BKV (284 pb); B) plasmids. Lines 1 to 10: Plasmids 
ranging from 1010 to 101 copies; line 11: the human beta-actin used as an endogenous control (220 pb); line 12: 100 bp DNA ladder 
(New England Biolabs, USA) 
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explain the small number of existing protocols. BKV and 
JCV are classified into major subtypes (4 BKV and 7 JCV) 
that are further subdivided into geographically dispersed 
genotypes15,16. Therefore, the inclusion of these variants 
should be considered under the penalty of a misdiagnosis. 
For instance, using the protocol established by Fedele et 
al.17, which is the most referenced method for simultaneous 
detections of BKV and JCV, 7 patients of our study were 
co-infected with JCV and BKV. However, the sequencing 
analysis confirmed only BKV, which was further confirmed 
by our primer sets. Therefore, the conclusion was that 
the JCV primers described by these authors were not 
specific, probably due to the extensive degeneration of the 
primer sequences. In 2000, Bofil-Mas et al.18 developed 
an interesting multiplex tool for BKV and JCV diagnosis, 
although the nested reaction required a separated BKV and 
JCV amplification. More recent publications on multiplex 
PCR for both viruses are based on the methodology 
described by Fedele et al.19 which can, as shown, generate 
non-specific results, and also the methodology proposed 
by Bofil-Mas et al. 20. 
Although real-time PCR is the standard diagnosis for 
polyomaviruses, the use of qualitative methods may be of 
interest in centers that lack the infrastructure or receive 
a small number of samples to compensate for the use of 
more expensive diagnostic methods. In addition, qualitative 
tests have shown to be compatible with quantitative tests 
for detecting BKV in blood samples (unpublished data).
Based on our results, we conclude that the original 
duplex snPCR presented here is a sensitive, specific and 
reliable molecular methodology to detect and differentiate 
BKV and JCV in clinical samples. Although we established 
the technique using samples from renal recipients only, we 
could extend it to other types of biological materials from 
patients presenting different clinical manifestations. 
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